Eduardo L Franco Selected Research

Squamous Intraepithelial Lesions

10/2020	A Pooled Analysis to Compare the Clinical Characteristics of Human Papillomavirus-positive and -Negative Cervical Precancers.
1/2019	Lack of Association between Human Papillomavirus Types 6 and 11 Genetic Variants and Cervical Abnormalities: The Ludwig-McGill Cohort Study.
12/2013	The association between human leukocyte antigen (HLA)-G polymorphisms and human papillomavirus (HPV) infection in Inuit women of northern Quebec.
1/2013	Accuracy of p53 codon 72 polymorphism status determined by multiple laboratory methods: a latent class model analysis.
8/2010	No association between endogenous retinoic acid and human papillomavirus clearance or incident cervical lesions in Brazilian women.
6/2009	Low-risk human papillomavirus type 6 DNA load and integration in cervical samples from women with squamous intraepithelial lesions.
3/2009	Persistence of an incident human papillomavirus infection and timing of cervical lesions in previously unexposed young women.
12/2007	Viral load of episomal and integrated forms of human papillomavirus type 33 in high-grade squamous intraepithelial lesions of the uterine cervix.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eduardo L Franco Research Topics

Disease

52	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 01/2003
48	Neoplasms (Cancer) 01/2022 - 09/2003
43	Papillomavirus Infections 01/2022 - 07/2002
43	Infections 01/2022 - 07/2002
15	Uterine Cervical Dysplasia 11/2021 - 11/2003
8	Squamous Intraepithelial Lesions 10/2020 - 12/2007
8	Persistent Infection 10/2012 - 01/2003
6	Warts (Wart) 07/2014 - 04/2011
5	Sexually Transmitted Diseases (Sexually Transmitted Disease) 10/2019 - 03/2006
5	Prostatic Neoplasms (Prostate Cancer) 01/2012 - 04/2006
4	Coinfection 07/2020 - 06/2009
3	Atypical Squamous Cells of the Cervix 01/2019 - 01/2011
3	Endometrial Neoplasms (Endometrial Cancer) 01/2017 - 09/2010
3	Carcinoma (Carcinomatosis) 01/2011 - 09/2003
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2019 - 11/2012
2	Obesity 01/2019 - 08/2004
2	Papilloma (Papillomatosis) 07/2014 - 10/2012
2	Genetic Risk Score 12/2013 - 01/2012
2	Inflammation (Inflammations) 07/2012 - 03/2006
2	Carcinogenesis 05/2012 - 11/2003
2	Ovarian Neoplasms (Ovarian Cancer) 01/2008 - 11/2002
1	Penile Neoplasms (Penile Cancer) 01/2022
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2019
1	Hepatitis B 01/2019
1	Multiple Endocrine Neoplasia Type 2a (MEN 2) 01/2018
1	Gonorrhea 01/2018
1	Communicable Diseases (Infectious Diseases) 01/2018
1	Urinary Bladder Neoplasms (Bladder Cancer) 03/2015
1	Lung Neoplasms (Lung Cancer) 05/2013

Drug/Important Bio-Agent (IBA)

41	VaccinesIBA 01/2022 - 01/2003
29	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 01/2003
22	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2022 - 11/2004
11	Biomarkers (Surrogate Marker)IBA 10/2020 - 06/2008
8	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 07/2002
6	Oral ContraceptivesIBA 10/2019 - 09/2003
5	CarrageenanIBA 01/2022 - 01/2020
4	Combined VaccinesIBA 01/2021 - 10/2012
4	AntigensIBA 07/2020 - 11/2003
4	HLA-DRB1 Chains (HLA DRB1)IBA 11/2018 - 07/2002
4	Codon (Codons)IBA 01/2013 - 01/2004
3	ORALIT (ORS)IBA 01/2022 - 03/2008
3	Contraceptive Agents (Contraceptives)IBA 01/2022 - 04/2011
3	EnzymesIBA 04/2019 - 03/2010
3	Acetic Acid (Vinegar)FDA LinkGeneric 01/2017 - 09/2006
3	HLA-G Antigens (HLA G)IBA 05/2014 - 04/2011
3	arginylarginine (Arg-Arg)IBA 01/2013 - 01/2004
3	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2011 - 04/2006
2	LubricantsIBA 01/2022 - 01/2020
2	Pharmaceutical PreparationsIBA 01/2021 - 04/2006
2	RadonIBA 01/2019 - 01/2018
2	Lugol's solution (Lugol's iodine)IBA 01/2017 - 09/2006
2	Biological ProductsIBA 05/2014 - 01/2011
2	AntibodiesIBA 01/2011 - 03/2010
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2010 - 04/2006
2	arginylprolineIBA 01/2005 - 01/2004
2	prolyl-proline (Pro-Pro)IBA 01/2005 - 01/2004
2	Estrogens (Estrogen)FDA Link 08/2004 - 11/2003
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Messenger RNA (mRNA)IBA 11/2021
1	RNA (Ribonucleic Acid)IBA 11/2021
1	25-hydroxyvitamin DIBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Vitamin D FDA LinkGeneric 01/2021
1	Glutathione Transferase (Glutathione S-Transferase)IBA 04/2019
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 04/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	antineoplaston A10 (A 10)IBA 01/2019
1	Tobacco Smoke Pollution (Passive Smoking)IBA 01/2019
1	HLA-DRB5 Chains (HLA DRB5)IBA 11/2018
1	HLA-DRB3 Chains (HLA DRB3)IBA 11/2018
1	Hormones (Hormone)IBA 01/2017
1	Amino Acids FDA Link 01/2017
1	HLA-B Antigens (HLA-B)IBA 01/2017
1	HLA-DQB1 antigen (HLA DQB1)IBA 05/2014
1	Biological FactorsIBA 05/2014
1	Immunologic Factors (Immunomodulators)IBA 05/2014
1	VitaminsIBA 12/2013
1	MethyltransferasesIBA 12/2013
1	Folic Acid (Vitamin M)FDA LinkGeneric 12/2013
1	Reduced Folate Carrier ProteinIBA 12/2013
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 12/2013
1	methionine synthase reductaseIBA 12/2013
1	HomocysteineIBA 12/2013
1	Toll-Like Receptor 9IBA 08/2013
1	Toll-Like Receptors (Toll-Like Receptor)IBA 08/2013
1	Bacterial AntigensIBA 05/2013

Therapy/Procedure

8	Secondary Prevention 12/2020 - 01/2003
5	Condoms (Condom) 01/2018 - 03/2006
4	Therapeutics 01/2019 - 11/2003
3	Continuity of Patient Care 12/2021 - 08/2007
2	Male Circumcision 01/2022 - 03/2004
2	Hysterectomy 12/2018 - 01/2018
1	Treatment Delay 01/2022
1	Aftercare (After-Treatment) 08/2021
1	Radiotherapy 01/2017
1	Injections 03/2016
1	Hormonal Contraception 01/2016
1	Cystectomy 03/2015
1	Investigational Therapies (Experimental Therapy) 05/2013
1	Perioperative Period 05/2013